Literature DB >> 24860121

Long-term outcome in Japanese patients with lupus nephritis.

M Kono1, S Yasuda2, M Kato1, Y Kanetsuka1, T Kurita1, Y Fujieda1, K Otomo1, T Horita1, K Oba3, M Kondo4, M Mukai4, M Yanai5, Y Fukasawa5, T Atsumi1.   

Abstract

The objective of this study was to clarify the long-term outcome in patients with lupus nephritis (LN) according to the International Society of Nephrology and Renal Pathology Society classification. This retrospective analysis comprised 186 Japanese patients given a diagnosis of LN by renal specimen with a mean observation period of 12 years. Primary end point was defined as death or end-stage renal disease, and standardized mortality ratios were calculated. Five patients presented with histopathological class I, 62 with II, 21 with III or III+V, 73 with IV or IV+V and 25 with V. Fourteen deaths occurred, corresponding to an overall standardized mortality ratio of 3.59 (95% confidence interval 2.02-5.81, p < 0.0001). Kaplan-Meier analysis revealed a 10-year overall survival of 95.7%. Nephrotic proteinuria (≥3.5 g/day) at baseline was identified as an independent poor prognostic factor for overall survival in Cox regression analysis. Kaplan-Meier analysis revealed a 10-year renal survival as 94.3%. Male gender and nephrotic proteinuria at baseline were identified as independent poor prognostic factors for renal survival in Cox regression analysis. In conclusion, LN was associated with a 3.59-fold increase in mortality compared with the general population. Male gender and nephrotic proteinuria were predictive for poor renal outcome.
© The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  Nephritis; renal lupus; systemic lupus erythematosus

Mesh:

Year:  2014        PMID: 24860121     DOI: 10.1177/0961203314536246

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  9 in total

Review 1.  Lupus Nephritis in Asia: Clinical Features and Management.

Authors:  Desmond Y H Yap; Tak Mao Chan
Journal:  Kidney Dis (Basel)       Date:  2015-08-05

2.  Regional variations in immunosuppressive therapy in patients with primary nephrotic syndrome: the Japan nephrotic syndrome cohort study.

Authors:  Ryohei Yamamoto; Enyu Imai; Shoichi Maruyama; Hitoshi Yokoyama; Hitoshi Sugiyama; Kosaku Nitta; Tatsuo Tsukamoto; Shunya Uchida; Asami Takeda; Toshinobu Sato; Takashi Wada; Hiroki Hayashi; Yasuhiro Akai; Megumu Fukunaga; Kazuhiko Tsuruya; Kosuke Masutani; Tsuneo Konta; Tatsuya Shoji; Takeyuki Hiramatsu; Shunsuke Goto; Hirofumi Tamai; Saori Nishio; Arimasa Shirasaki; Kojiro Nagai; Kunihiro Yamagata; Hajime Hasegawa; Hidemo Yasuda; Shizunori Ichida; Tomohiko Naruse; Kei Fukami; Tomoya Nishino; Hiroshi Sobajima; Satoshi Tanaka; Toshiyuki Akahori; Takafumi Ito; Terada Yoshio; Ritsuko Katafuchi; Shouichi Fujimoto; Hirokazu Okada; Eiji Ishimura; Junichiro James Kazama; Keiju Hiromura; Tetsushi Mimura; Satashi Suzuki; Yosuke Saka; Tadashi Sofue; Yusuke Suzuki; Yugo Shibagaki; Kiyoki Kitagawa; Kunio Morozumi; Yoshiro Fujita; Makoto Mizutani; Takashi Shigematsu; Naoki Kashihara; Hiroshi Sato; Seiichi Matsuo; Ichiei Narita; Yoshitaka Isaka
Journal:  Clin Exp Nephrol       Date:  2018-04-20       Impact factor: 2.801

3.  Assessment of serum macrophage migration inhibitory factor (MIF), adiponectin, and other adipokines as potential markers of proteinuria and renal dysfunction in lupus nephritis: a cross-sectional study.

Authors:  Jorge Ivan Gamez-Nava; Valeria Diaz-Rizo; Edsaul Emilio Perez-Guerrero; Jose Francisco Muñoz-Valle; Ana Miriam Saldaña-Cruz; Nicte Selene Fajardo-Robledo; Heriberto Jacobo-Cuevas; Cesar Arturo Nava-Valdivia; Miriam Fabiola Alcaraz-Lopez; Xochitl Trujillo; Miguel Huerta; Ernesto German Cardona-Muñoz; Laura Gonzalez-Lopez
Journal:  Biomark Res       Date:  2020-10-28

Review 4.  Global epidemiology of systemic lupus erythematosus.

Authors:  Megan R W Barber; Cristina Drenkard; Titilola Falasinnu; Alberta Hoi; Anselm Mak; Nien Yee Kow; Elisabet Svenungsson; Jonna Peterson; Ann E Clarke; Rosalind Ramsey-Goldman
Journal:  Nat Rev Rheumatol       Date:  2021-08-03       Impact factor: 32.286

5.  Lupus Nephritis in Males: Clinical Features, Course, and Prognostic Factors for End-Stage Renal Disease.

Authors:  Andrés Urrestarazú; Gabriela Otatti; Ricardo Silvariño; Mariela Garau; Ruben Coitiño; Asunción Alvarez; Esther Gonzalez; Liliana Gadola; Manuel Praga; Oscar Noboa
Journal:  Kidney Int Rep       Date:  2017-06-16

6.  Comparison of complete renal response and mortality in early- and late-onset lupus nephritis: a multicenter retrospective study of a Japanese cohort.

Authors:  Kunihiro Ichinose; Mineaki Kitamura; Shuntaro Sato; Keita Fujikawa; Yoshiro Horai; Naoki Matsuoka; Masahiko Tsuboi; Fumiaki Nonaka; Toshimasa Shimizu; Remi Sumiyoshi; Tomohiro Koga; Shin-Ya Kawashiri; Naoki Iwamoto; Takashi Igawa; Mami Tamai; Hideki Nakamura; Tomoki Origuchi; Tomoya Nishino; Atsushi Kawakami
Journal:  Arthritis Res Ther       Date:  2020-07-22       Impact factor: 5.156

7.  Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS).

Authors:  Ryohei Yamamoto; Enyu Imai; Shoichi Maruyama; Hitoshi Yokoyama; Hitoshi Sugiyama; Kosaku Nitta; Tatsuo Tsukamoto; Shunya Uchida; Asami Takeda; Toshinobu Sato; Takashi Wada; Hiroki Hayashi; Yasuhiro Akai; Megumu Fukunaga; Kazuhiko Tsuruya; Kosuke Masutani; Tsuneo Konta; Tatsuya Shoji; Takeyuki Hiramatsu; Shunsuke Goto; Hirofumi Tamai; Saori Nishio; Arimasa Shirasaki; Kojiro Nagai; Kunihiro Yamagata; Hajime Hasegawa; Hideo Yasuda; Shizunori Ichida; Tomohiko Naruse; Tomoya Nishino; Hiroshi Sobajima; Satoshi Tanaka; Toshiyuki Akahori; Takafumi Ito; Yoshio Terada; Ritsuko Katafuchi; Shouichi Fujimoto; Hirokazu Okada; Eiji Ishimura; Junichiro J Kazama; Keiju Hiromura; Tetsushi Mimura; Satoshi Suzuki; Yosuke Saka; Tadashi Sofue; Yusuke Suzuki; Yugo Shibagaki; Kiyoki Kitagawa; Kunio Morozumi; Yoshiro Fujita; Makoto Mizutani; Takashi Shigematsu; Naoki Kashihara; Hiroshi Sato; Seiichi Matsuo; Ichiei Narita; Yoshitaka Isaka
Journal:  Clin Exp Nephrol       Date:  2020-03-07       Impact factor: 2.801

8.  Outcomes of membranous and proliferative lupus nephritis - analysis of a single-centre cohort with more than 30 years of follow-up.

Authors:  Filipa Farinha; Ruth J Pepper; Daniel G Oliveira; Thomas McDonnell; David A Isenberg; Anisur Rahman
Journal:  Rheumatology (Oxford)       Date:  2020-11-01       Impact factor: 7.046

Review 9.  Amino Acid Metabolism in Lupus.

Authors:  Michihito Kono; Nobuya Yoshida; George C Tsokos
Journal:  Front Immunol       Date:  2021-02-22       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.